 Acupuncture analgesia is based on ATP release from (sub)cutaneous/muscular tissue  ATP and its degradation product adenosine participate in acupuncture analgesia  Peripheral and central mechanisms participate in the effect of acupuncture analgesia  A1/P2X3,4,7 receptors appear to mediate acupuncture analgesia
A C C E P T E D M A N U S C R I P T Introduction Liu et al. (1994) were probably the first to report that weak electro (E)-acupuncture (AP) applied to the acupoints Yanglingquan (GB34) and Xuanzhong (GB39) prolonged the latency of nociceptive hind limb withdrawal reflex, and that the intraperitoneal administration of two adenosine receptor (R) antagonists, theophylline and caffeine, blocked the EAP-induced analgesia. Since that time recognition of the roles of purines in acupuncture analgesia (AA) has gradually increased. In 2009, Professor Geoffrey Burnstock, who presented previously the hypothesis of purinergic signaling (Burnstock, 1972) , proposed a crucial role for purines in AA (Burnstock, 2009b) . He pointed out that sensory nerve activity initiated in the skin by AP is likely to have an inhibitory modulating effect on the spinoparabrachial and spinothalamic tracts to the brain pain centers by a mechanism which still remains to be clarified.
The purinergic signaling system includes ATP, ADP, AMP and adenosine (ADO), and two families of purinoceptors called P1 and P2, for ADO and ATP/ADP (UTP/UDP), respectively (Burnstock, 1978) . These receptors are expressed in most cell types in A C C E P T E D M A N U S C R I P T 3 mammalians but also in invertebrates or more primitive creatures (Burnstock and Knight, 2004; Koles et al., 2007) . P1Rs consist of four subtypes: A1, A2A, A2B and A3, all of which are coupled to G proteins. P2Rs are classified into two families: P2X and P2Y. P2XRs are ligand-gated cationic channels forming the P2X1-7 subtypes and P2YRs belong to G protein-coupled receptors consisting of the P2Y1,2,4,6,11-14 subtypes. The role of purinergic signaling in pain has been confirmed and a great number of candidate drugs for this therapeutic indications have been developed in this field (Burnstock, 2009a (Burnstock, , 2016 (Burnstock, , 2017 (Burnstock, , 2018 Ford, 2012; Park and Kim, 2016) Evidence for the roles of ADO and A1Rs in AA has been provided by supplying solid data in mice (Goldman et al., 2010) and healthy human volunteers (Takano et al., 2012) . Further, a new concept of acupuncture therapy, PAPuncture has been described (Hurt and Zylka, 2012) , by injecting prostatic acid phosphatase (PAP; an ectonucleotidase that dephosphorylates extracellular AMP to ADO) into the space behind the knee that encompasses the acupoint Weizhong (BL40). PAPuncture caused analgesia for an extended period of time considerably surmounting the duration of the effect of AP alone.
ATP/ADP concentration and acupuncture stimulation
ATP and its metabolite ADP are the main purinergic ligands binding to P2 receptors.
Under physiological conditions, intracellular concentrations of ATP are in the range of 3-5 mM and serve for the storage of energy; they are mobilized under anaerobic conditions. Noxious stimuli, shear stress, stretch, osmotic swelling or metabolic limitation cause the release of ATP/ADP into the extracellular space from the interior of the afflicted cells (Lazarowski, 2012) . Typically, ATP concentration required for half maximal activation of purinergic receptors is 3-500 nM, which is 1,000-fold lower than those existing inside the cell and sufficient to initiate purinergic receptor-mediated signaling. After having been released into the extracellular space, ATP acts at P2Rs and is degraded into ADP, AMP and ADO by different ecto-nucleotidases (Yegutkin, 2008) . The P2X7R-type has a uniquely low sensitivity to ATP in the range of 100-1,000 µM (Sperlagh et al., 2006; Sperlagh and Illes, 2014; Xing et al., 2016) . Fig. 1 shows some AP family procedures leading to the local release of ATP and the generation of its functionally active metabolites, as well as the receptor types at which
these purinergic agonists act. Currently, only few data are available on the changes of extracellular ATP concentration after acupuncture stimulation. In male mice, a small acupuncture needle was gently inserted into the Zusanli point (ST36) located 3-4 mm below and 1-2 mm lateral from the midline of the knee (Goldman et al., 2010) . Gentle manual rotations of the acupuncture needle every 5 min for a total of 30 min sharply increased the extracellular concentrations of all detected purines (ATP, ADP, AMP and ADO) as measured in the muscle/subcutaneous tissue 0.4-0.6 mm apart from the acupoint by a microdialysis probe. ADO concentration increased ~24-fold during the 30-min acupuncture session. ADP, AMP and ADO remained markedly elevated 60 min after AP. However, the extracellular concentration of ATP returned to baseline soon after needling (Goldman et al., 2010) . In healthy volunteers, AP also caused a marked, long-lasting increase of ADO, but not ATP concentrations during acupuncture (Takano et al., 2012) . Already these findings suggest that ADO, instead of its mother compound ATP was responsible for the analgesic effect of AP in mice and human volunteers. The below experimental data have lent further support to this notion.
Deoxycoformycin blocks AMP deaminase and ADO deaminase which help to generate extracellular ADO from ATP (Goldman et al., 2010) . The intraperitoneal application of deoxycoformycin to mice both sharply increased the concentration of ADO in muscle/subcutaneous tissue during and after AP as well as significantly prolonged the ensuing anti-nociception. Therefore it appeared most likely that extracellular ADO was generated enzymatically from the released ATP rather than by the operation of an outward transporter/release mechanism of ADO itself from the cell interior into the interstitial space.
Experiments on Sprague-Dawley rats in vivo and mast cell cultures in vitro delivered data on changes in the concentration of ATP in response to different forms of AP stimulation. In rats, administration of sparrow-pecking manual acupuncture (MAP) technique on the right tibialis anterior muscle at a location 7-8 mm below the knee (without naming the acupoint) and at 30 repetitions per min for 1 min induced significant increase of the extracellular concentrations of ATP and ADP as well as ADO rather than AMP at the 30 min time-point. 60 min after MA, all four purine substances returned to baseline values. It was proposed that the increased ATP concentration induced by MAP could derive from skeletal muscle cells rather than vascular cells or sensory nerves (Nagaoka et al., 2016) . Another experiment to measure ATP concentration was performed on rat neck-incision pain model . The neck incision induced
an increase in ATP content in the dorsal part of the cervico-spinal cord 4, 24, and 48 h post-incision. One session of EAP intervention further elevated the ATP levels in all three EAP groups (LI18, LI4-PC6 and ST36-GB34). However, after two sessions of EAP intervention, the ATP levels decreased in both LI18 and LI4-PC6 groups and returned to the normal level after three sessions of EAP. EAP at ST36-GB34 did not cause significant changes 24 and 48 h post-incision. It seems that EAP only cause a sudden and short increase in ATP concentration which rapidly fades thereafter.
In fact, treatment of the skin at the acupoint is a necessary measure in most therapies of AP family procedures. Accordingly, current data demonstrate that mast cells of acupoints participate in the mechanism of analgesia when stimulated during needling (Zhang et al., 2008) , moxibustion (Shi et al., 2011) and laser acupuncture (Cheng et al., 2009) . In in vitro experiments on cells of the human mast-cell line HMC-1, mechanical stress was induced by superfusion of the cells with hypotonic solution, heat was generated by incubation of the cells at 43 °C or 52°C, and red laser light of 657 nm wavelength was used for irradiation. It was found that all these stimuli induced ATP release from human HMC-1 cells, and this release was associated with an increase of the intracellular free Ca 2+ concentration (Cheng et al., 2009; Zhang et al., 2008) . activation or after enzymatic degradation to ADO via A1R activation in the alleviation of pain is shown in Fig. 2 .
P2X3 and P2X2/3 receptors in acupuncture analgesia
In 1995, the P2X3R was cloned and shown to be localized predominantly at the terminals of Aδ and C fibres projecting from sensory neurons of dorsal root ganglia (DRG) to the innervated tissues in most tissues and organ systems, including skin, joints, and hollow organs, suggesting a high degree of specificity to the pain sensing system in the human body (Chen et al., 1995; Lewis et al., 1995) . The homomeric P2X3Rs respond to the ATP structural analogue α,β-methylene ATP (α,β-meATP) and desensitize rapidly during agonist application. The heteromeric P2X2/3Rs are also sensitive to ATP/α,β-meATP, but do not exhibit desensitizing properties. Both P2X3 and P2X2/3Rs were identified to participate in acute, inflammatory, neuropathic and cancer pain in a variety of experimental pain models Burnstock, 2006) . and antisense oligonucleotides or non-selective antagonists (suramin) improve different pain conditions in animal models (Ford, 2012; Kennedy et al., 2003; Donnelly-Roberts et al., 2008) . Additionally, in experimental pain states, mice with genetic deletion of P2X3Rs also display decreased nocifensive behavior in comparison with their wild-type backgrounds. Therefore, reducing the concentration of local ATP or inhibitory modulation of P2X3-containing receptors appears to be an exciting new approach in pain management (Hansen et al., 2012; Prado et al., 2013; Schiavuzzo et al., 2015; Mansoor et al., 2016) .
Most studies investigating the effects of purines (acupurines) released by AP stimulation have dealt with the role of P2X3Rs or P2X2/3Rs in AP-mediated analgesia, including neuropathic pain, inflammatory pain and visceral pain using different acupoints for different pain modalities.
In rat neuropathic pain induced by constricting one sciatic nerve with a ligature (chronic constriction injury; CCI), EAP was employed to ipsilateral or contralateral acupoints (Zusanli, ST36; Yanglinquan, GB34) for 30 min daily and for 7 days in total starting 7 days post CCI (Wang et al., 2014; Tu et al., 2012; Cheng et al., 2013) .
Hyperalgesia and allodynia, as two symptoms of neuropathic pain were measured for 14 days in total. During the first 7 days of observation, the severity of these two
symptoms gradually increased and then reached a maximum level. The mentioned AP treatment schedules caused a gradual and moderate reversal of neuropathy by about 40%; the recovery was almost identical for mechanical pain and temperature sensation, but was practically indistinguishable for the ipsi-and contralateral EAP. On the 10th day, intrathecal injection of the selective P2X3R antagonist A317491 immediately and dramatically facilitated the EAP-induced analgesia (Wang et al., 2014) . In this experiment, A317491 was applied only in combination with EAP but never alone and thereby it is difficult to decide whether the two effects were additive or not. An additive interaction would indicate that the mechanism of analgesia is the same, mediated in both cases by the exclusion of P2X3R function. However, the equal efficiency of ipsiand contralateral EAP implied that the spinal or supraspinal level rather than the peripheral terminals of DRG neurons would be important to cause pain relief after EAP.
Another series of experiments with EAP at the same acupoints in the CCI rat model, induced by sciatic nerve ligation, led to very similar results. However, a different timeschedule was used which appears to be sub-optimal. EAP at Zusanli-Yanglingquan acupoints 3 days after ligating the sciatic nerve induced moderate analgesia.
Extracellular signal-regulated kinase 1/2/P2X3R signal pathway in the spinal cord was proposed to be a potential mechanism of AA (Yu et al., 2013) . It may be criticized that the effect of EAP in this study could not be reliably evaluated, because neuropathic pain does not reach its maximum intensity at the early time-point of 3 days. Further, all studies reported an increase of the α,β-meATP-induced current amplitudes in acutely dissociated DRG neurons of CCI rats (Tu et al., 2012; Cheng et al., 2013; Wang et al., 2014) . In rats, treated ipsi-or contralaterally with EAP, the α,β-meATP currents decreased, but still exceeded the current amplitudes measured in non-neuropathic DRGs. EAP also moderately reduced the increased expression of P2X3R mRNA/protein detected by quantitative RT-PCR, in situ hybridization, quantitative immunohistochemistry, and western blotting in DRG neurons and the dorsal horn of spinal cord after CCI to the unilateral sciatic nerve (Wang et al., 2014; Tu et al., 2012 , Yu et al., 2013 . In accordance with the increased expression of P2X3R mRNA/protein in DRG or spinal cord of neuropathic rats, crucial sites in the endogenous pain modulatory systems, in the midbrain periaqueductal gray (PAG) also showed upregulated P2X3R protein levels (Xiao et al., 2010) . EAP at Zusanli and Sanyinjiao (SP6) ipsilateral to the side of the ligated nerve upregulated the P2X3R protein, whereas sham-acupuncture was ineffective. Interestingly, knock-down of the upregulated P2X3R The positive effects of EAP were observed also in case of diabetic neuropathic pain (DNP) and inflammatory pain by stimulating acupoints Zusanli (ST36) and Kunlun (BL60) with 2 and 100 Hz frequencies. In DNP rats, thermal hyperalgesia measured by paw withdrawal latency was drastically reduced (He et al., 2017) . EAP with 2 Hz exhibited stronger analgesic effect than that caused by 100 Hz. The expression of P2X3R protein in lumbar (L4-L6) DRGs was assessed by immunofluorescence.
Interestingly, EAP with 2 Hz reduced the increased expression of P2X3Rs in L4-L6 DRGs of DNP rats whereas EAP induced by 100 Hz stimulation reduced it only in L5 and L6 DRGs. It seems that low frequency EAP involved more spinal cord segments with the attached DRGs contributing to the stronger analgesic effect of 2 Hz over that of 100 Hz. In contrast, when inflammatory pain was induced by intraplantar injection of Freund's Complete Adjuvant (CFA) into the right hind paw, 100 Hz EAP generated stronger analgesic effect than EAP with 2 Hz (Fang et al., 2018) . Then, the number of Visceral pain also responded to AP. The painful irritable bowel syndrome was modelled in few days old rats by inflating a balloon in their terminal colon twice daily for 14 days in total (Weng et al., 2013 (Weng et al., , 2015 . Within a further period of 6 weeks, these rats developed hypersensitivity to bowel distension. To determine the intensity of pain reaction caused by subsequent colorectal distension, an arbitrary withdrawal reflex score was used. In pressure-treated rats, the pain withdrawal score decreased after EAP (at acupoint ST37 and ST25) in a reversible manner. The levels of P2X2 and P2X3 mRNAs in DRGs also responded with increase and decrease to balloon distension and EAP, respectively. Similar changes of P2X3 mRNA were also found in colon myenteric plexus, spinal cord, prefrontal cortex and anterior cingulate cortex. Thus, it is assumed that P2X3Rs became upregulated along the neuronal pathways mediating pain to higher brain centers. Nonetheless, we are left with some justified doubt, because the criteria to prepare the spinal cord for RT-PCR were not reported in the discussed
papers. Of course the spinal cord segments L4-L6 innervated by the appropriate DRGs should be prepared (optimally only their dorsal parts containing the dorsal horn) and processed for RT-PCR. The major deficit of these studies is that sham EAP is almost always missing from the experimental designs; electrical stimulation by AP needles inserted at non-acupoints is, however, an indispensable control procedure. 
P2X4 receptors and acupuncture analgesia

P2X7 receptors and acupuncture analgesia
The P2X7R is an unusual member in P2XR superfamily. First, the C-terminal domain is some 200 amino acids longer than that of the other superfamily members and has been implicated in regulating receptor function including activation of signaling pathways, cellular localization, protein-protein interactions, and post-translational modification (Costa-Junior et al., 2011) . Secondly, the P2X7R can function as a bifunctional receptor, i.e., either as a non-selective cationic channel after activation by relatively low concentrations of ATP, which however may form on long-lasting activation by high ATP concentrations large diameter non-selective pores with permeability to molecules of molecular mass up to ~900Da (Surprenant et al.,1996; Pelegrin and Surprenant, 2006; Locovei et al., 2007) . The first evidence for the involvement of P2X7Rs in chronic inflammatory and neuropathic pain was derived from a study with P2X7R-deficient mice (Chessell et al., 2005) . Currently, the general belief is that P2X7Rs are also involved in bone cancer pain, extra-territorial facial pain, diabetic neuropathic pain, chronic postsurgical pain and chronic pain sensitivity associated with chronic inflammatory and neuropathic pain (Inoue et al., 2007; Carroll et al., 2009; Wu et al., 2017; Li et al., 2017; Liu et al., 2017; Falk et al., 2015; Ying et al., 2014; Murasaki et al., 2013; Sorge et al., 2012) . Activation of the apoptotic caspase enzyme cascade and induction of a rapid maturation and release of the pro-inflammatory cytokine interleukin-1β (IL-1β) by P2X7Rs and their distribution at peripheral and central immunocytes (lymphocytes, monocytes/macrophages, microglia, astrocytes) enables them to become key players at the neuroimmune interface (Carroll et al., 2009; Burnstock et al., 2011) . Systemic application of P2X7R antagonists such as A-438079 produced dose-dependent antinociceptive effects in models of neuropathic (Nelson et al., 2006) and inflammatory pain (Honore et al., 2006) . Administration of TAT-P451, a peptide corresponding to the P2X7R C-terminal domain, which blocked pore formation
but not cation channel activity, selectively reduced nerve injury and inflammatory allodynia only in mice with the pore-forming P2rx7 allele (Sorge et al., 2012) . In the case of neuropathic pain, P2X7Rs located at satellite glial cells (astrocyte-like cells in sensory ganglia) initiate an inflammatory reaction (Villa et al., 2010) . Accordingly, disruption of P2X7Rs not only altered inflammatory pain but also reduced pain associated with nerve injury (Chessell et al., 2005) .
The role of P2X7Rs in AA has been tested in three different types of pain models.
Visceral hyperalgesia treated with moxibustion was firstly investigated. In this series of experiments, a new moxibustion manipulation technique, named heat-sensitive moxibustion (HSM) was used . That is, Dachangshu acupoint (BL25) or a nearby non-acupoint (1 cm outside of BL25) were heated by moxibustion using a moxibustion cigar produced from mugwort four times a day for 8 consecutive days. It was reported that HSM at BL25 significantly decreased the abdominal withdrawal reflex scores and the up-regulation of P2X7Rs in L6-S1 DRGs caused by balloon distension was also prevented by moxibustion as documented by quantitative immunohistochemistry, real-time RT-PCR, and western blotting.
The second study was performed in CCI-induced neuropathic pain with EAP at Huantiao acupoint (Xu et al., 2016) . EAP was applied at a frequency of 2 Hz for 30 minutes per day. EAP treatment was initiated on the day after CCI surgery or dibenzoyl-ATP (BzATP) intrathecal injection and lasted for 14 days. EAP at Huantiao acupoint increased paw withdrawal threshold on day 5 and paw withdrawal latency on day 7.
EAP also inhibited spinal P2X7 immunoreactive microglia activation induced by CCI or BzATP administration, which was accompanied by the suppression of spinal IL-1β and IL-18 overexpression.
Finally, neck-incision pain model was also used to underline the role of P2X7Rs in AA . Under isoflurane inhalational anesthesia, repeated blunt dissection stimulation along the bilateral sternohyoideus around the thyroid gland regions for 30 min with a forceps was applied to induce neck-incision pain model. Thermal pain thresholds were tested before and after the neck-incision surgery (4 h after each EAP intervention). EAP stimulation (2 Hz/100 Hz frequency) under light anesthesia with isoflurane at bilateral LI18 or LI4-PC6 at bilateral Zusanli (ST36)-Yanglingquan (GB34) was applied during the process of neck-incision surgery. These experiments demonstrated that two sessions of EAP stimulation of both LI18 and LI4-PC6, but not ST36-GB34, attenuated the thermal hyperalgesia of the local neck incision region in this
pain model. These results implied that, to maintain homeostasis at the early stage of neck incision, EAP may suppress fractalkine/CX3CR1/p38 MAPK-induced neuronmicroglia crosstalk through regulation of ATP release and P2X7R activity in microglia.
Acupuncture-induced analgesia: ATP versus adenosine effects
Acupurines are promising signaling molecules to explain the mechanism of acupuncture, especially in AA. This complements a theory according to which mainly central opioids are responsible for analgesia caused by AP, and in addition it provides an explanation for the observed effectiveness of AP in human patients. It is proposed that the mechanical, electrical or thermal stimulation of acupoints by AP needles, as well as moxibustion or cupping causes the release of ATP, which can be enzymatically degraded to a whole range of biologically active metabolites (ATP, ADP, AMP, ADO) (Tang et al., 2016) . It is a remote possibility that the stimulation of any of the P2XR types releases ADO, but for this idea there is hitherto no experimental evidence. AP causes pain by acting at P2X3,4,7Rs, while ADP causes analgesia by acting at P2Y1,12Rs or pain by acting at P2Y1 or P2Y2Rs. Eventually, ADO has an analgesic activity especially via A1R stimulation, although under special conditions (inflammatory pain, A2ARs; neuropathic pain, A3Rs) other ADO receptor-types may also participate (Tang et al., 2016) .
In the course of the recent 10 years, it was unequivocally shown that A1Rs (P1Rs) mediate AA for inflammatory and neuropathic pain. However, further experiments demonstrated that the P2X family receptors (P2X2-4,7) have an increased expression and function in peripheral and central sensory neurons during inflammatory, neuropathic and visceral pain. It has also been shown that EAP or moxibustion at different acupoints on the one hand induced analgesia and on the other hand decreased the facilitated expression of P2X3,4,7R-types in DRG, spinal cord, pre-frontal cortex, nucleus accumbens and increased it in periaqueductal grey (Table 1) .
However, the modulation of P2XR-types might be the consequence rather than the 
Further relevant questions
A number of interesting questions have been pointed out in our previous review (Tang et al., 2016) . Here we will update this previous list as follows: receptors were classified into three distinct groups (1) high affinity for ATP (P2X1, P2X3Rs); (2) lower affinity for ATP (P2X2-5Rs); (3) very low affinity for ATP (P2X7Rs).
Whereas some P2XRs rapidly desensitize (P2X1,3Rs), others desensitize only slowly.
Apart from a range of P2XRs also P2YRs might participate in AP-induced analgesia (Gerevich and Illes, 2004; Ando et al., 2010; Barragán-Iglesias et al., 2014 , 2016 . A further important point is that interactions between different purine receptors (e.g. P2X4 and P2X7, P2Y1 and P2X3) or between pain-sensitive purinoceptors and non-purinoceptors (e.g. TRPV1 and P2X3, ASIC3 and P2X3) can fine tune the analgesic effect of AP (Gerevich et al., 2007; Koles et al., 2008; Bernier et al., 2018; Stephan et al., 2018) . Thus, it should be clarified whether all these factors or only some of them are primarily involved in AA. (Berman et al., 2010; Hershman et al., 2018; Deng et al., 2018; Zhao et al., 2017; Scharf et al., 2006) . The question is which type(s) of P2 receptors is/are particularly involved in AA for these pain conditions.
Multiple and new experimental tools:
A real deficit of most studies elucidating the role of purines in AA is that a selective antagonist for P2X3Rs has been used only in some cases and P2X4 and P2X7R antagonists have not been utilized at all. It is an absolute necessity to use multiple and new experimental tools and methods in order to clarify the role of purinoceptors in AP-induced analgesia. These range from molecular biology to genetic engineering (knock-down, knock-out, gene editing), high-throughput sequencing, optogenetics, calcium imaging, Designer Receptors Exclusively Activated by Designer Drugs (DREADD), etc. (Latremoliere and Costigan, 2018; Moutal et al., 2017; Li et al., 2018; Xie et al., 2018; Anderson et al., 2018; Grace et al., 2018) .
AA in humans:
ATP, as the ligand of P2 receptors has been tested in clinical trials and showed analgesic effect on intravenous or intrathecal application (Hayashida et al., 2005) , although on subcutaneous application it proved to induce pain (Chizh and Illes, 2001 ). It appears likely that the analgesic effect was due to degradation to ADO and the subsequent activation of ADORs. There are no data available on the concentration of ATP in blood or preferably in the cerebrospinal fluid after AP. Moreover, an imminent question is whether single nucleotide polymorphisms of the involved P2 receptors (P2X7, P2Y12) (Sorge et al., 2012; Ide et al., 2014; Sumitani et al., 2018) might also modify the alleviation of pain by AP or contribute to distinguish the responders and nonresponders to AP with relation to analgesia.
Conclusions
Whereas there is unequivocal evidence that ATP is locally released by all forms of AP stimulation, and that this ATP serves as a precursor for ADO, which activates neuronal A1Rs, causing analgesia, the role of ATP itself is far from being understood in these processes. ATP is a sensory transmitter/modulator reinforcing nociception at all levels has to be considered in this respect. However, it may be hypothesized that the activation of P2X3,4,7Rs probably alters pain sensation by stimulating other neuronal pathways than those directly involved in the mediation of painful stimuli.
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